Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

The woman was diagnosed with Vogt–Koyanagi–Harada disease and successfully treated with medication, restoring her vision and stopping headaches.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.

Botulinum toxin-A may increase hair growth and reduce hair loss in men with baldness, and injecting near blood vessels can improve pain relief and last longer.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

The combination of tretinoin, minoxidil, and betamethasone valerate may cause severe scalp inflammation.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Transfected cells with VEGF and FGF2 genes improve skin wound healing by enhancing blood flow and regeneration.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Baricitinib shows promise for treating various skin conditions beyond alopecia areata.

A new treatment using hybrid vesicles with gold nanoparticles and finasteride significantly improves hair regrowth for androgenetic alopecia.

The new delivery method for dutasteride is more effective and has fewer side effects.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

The niosomes effectively target hair follicles for acne treatment.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Avacopan may cause unexpected side effects, so early monitoring is important.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.